Sign in
CompletedPhase 4

Methadone-Maintained Smokers Switching to E-Cigarettes

Key facts

Who runs it
Butler Hospital
Where
Providence, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 4
People taking part
183 people enrolled
Started
31 Mar 2022
Ended
30 Jun 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Electronic Cigarette
  • Nicotine Lozenge
Record updated
20 August 2026

Who can take part

Age
21 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • moderate to heavy cigarette smokers (10 cigarettes/day for > 1 yr; breath CO > 10 ppm)
  • have been receiving methadone for at least three months
  • attend at least weekly to receive methadone dose
  • speak English
  • have a telephone or access to a telephone
  • are available over the next 6 weeks
  • are interested in switching to either electronic cigarettes or nicotine replacement therapy

Who cannot take part

  • currently use medications that may reduce smoking (e.g., bupropion, varenicline, NRT)
  • daily medication for asthma or COPD
  • have unstable psychiatric conditions
  • use of ECs on > 2 of the past 30 days
  • have near-daily or daily use of marijuana
  • are pregnant
  • had a cardiovascular event in the last month

Where in United States

  • Butler HospitalProvidence, United States

About the trial

What the trial wants to find out

Participants in this randomized clinical trial will be methadone-maintained smokers interested in switching to electronic cigarettes (ECs). There will be a total of 7 study visits over the course of 6 weeks; each visit includes psychometric assessment and biomarker measurements. After completion of the baseline visit, participants will be randomized to either: 1) 6 weeks of EC use (JUUL 5% nicotine pods) or 2) 6 weeks of nicotine replacement therapy (NRT) in the form of nicotine lozenges. EC and NRT use will begin the day after the baseline assessment.

The 2 groups in the trial

  • Electronic CigarettesExisting treatment, for comparison

    Participants in this arm are randomized to receive electronic cigarettes for the 6-week study period.

    Treatment: Electronic Cigarette

  • Nicotine LozengesExisting treatment, for comparison

    Participants in this arm are randomized to receive nicotine lozenge for the 6-week study period.

    Treatment: Nicotine Lozenge

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 August 2026